The Wells Score for Pulmonary Embolism (PE) is a validated clinical prediction rule used to estimate the probability that a patient has an acute pulmonary embolism. Developed by Dr. Philip Wells and colleagues, the score combines recognised clinical findings and risk factors to provide an objective assessment of pre-test probability, supporting evidence-based investigation and management of suspected pulmonary embolism.
Pulmonary embolism is a manifestation of venous thromboembolism (VTE) in which thrombotic material, most commonly originating from a deep vein thrombosis (DVT) of the lower limbs, embolises to the pulmonary arterial circulation. Obstruction of pulmonary blood flow may impair gas exchange, increase right ventricular afterload, and lead to cardiovascular collapse in severe cases. Early diagnosis is therefore essential to reduce morbidity and mortality.
The Wells Score has become one of the most widely used clinical decision tools in emergency medicine, acute medicine, respiratory medicine, and primary care.
Purpose of the Wells Score
The Wells Score estimates the clinical probability of pulmonary embolism before definitive diagnostic testing is undertaken. By stratifying patients according to their likelihood of PE, the score supports appropriate use of laboratory investigations and imaging while reducing unnecessary exposure to ionising radiation and intravenous contrast.
Importantly, the Wells Score estimates pre-test probability and does not independently confirm or exclude the diagnosis of pulmonary embolism.
Clinical Criteria
The Wells Score assigns weighted points to recognised clinical features associated with pulmonary embolism, including:
- Clinical signs and symptoms of deep vein thrombosis
- Pulmonary embolism considered more likely than an alternative diagnosis
- Heart rate greater than 100 beats per minute
- Recent surgery or prolonged immobilisation
- Previous deep vein thrombosis or pulmonary embolism
- Haemoptysis
- Active malignancy
The cumulative score provides an estimate of the patient’s likelihood of pulmonary embolism and guides further diagnostic assessment.
Interpretation
Two validated interpretation models are commonly used in clinical practice.
Three-Level Classification
The original Wells model categorises patients as:
- Low probability
- Intermediate probability
- High probability
This approach estimates the likelihood of pulmonary embolism and supports decisions regarding subsequent investigation.
Two-Level Classification
Many contemporary clinical guidelines recommend the simplified two-tier model:
- Pulmonary embolism unlikely
- Pulmonary embolism likely
This classification is widely incorporated into modern diagnostic pathways alongside D-dimer testing.
Role in Diagnostic Assessment
The Wells Score forms part of a structured diagnostic strategy for suspected pulmonary embolism.
Assessment typically includes:
- Clinical history
- Physical examination
- Vital signs
- Wells Score calculation
- High-sensitivity D-dimer testing where appropriate
- Computed tomography pulmonary angiography (CTPA)
- Ventilation-perfusion (V/Q) scanning when CTPA is contraindicated or unsuitable
Patients with a low clinical probability and a negative high-sensitivity D-dimer can often have pulmonary embolism safely excluded without diagnostic imaging. Patients with a positive D-dimer or high clinical probability generally require prompt imaging to confirm or exclude the diagnosis.
This evidence-based approach improves diagnostic efficiency while limiting unnecessary investigations.
Clinical Applications
The Wells Score is routinely used in the assessment of patients presenting with features suggestive of pulmonary embolism, including:
- Acute dyspnoea
- Pleuritic chest pain
- Unexplained tachycardia
- Haemoptysis
- Syncope
- Hypoxaemia
- Suspected venous thromboembolism
The score also assists clinicians in determining the urgency of investigation and identifying patients who may require empirical anticoagulation while awaiting definitive imaging, in accordance with local clinical protocols.
Limitations
Although extensively validated, the Wells Score should not be used as a substitute for comprehensive clinical assessment.
Diagnostic accuracy may be influenced by:
- Pregnancy
- Active malignancy
- Hospitalised or postoperative patients
- Previous venous thromboembolism
- Chronic cardiopulmonary disease
- Atypical clinical presentations
- Alternative causes of dyspnoea or chest pain
Clinical judgement remains essential, particularly when the calculated score appears inconsistent with the patient’s overall presentation or when significant clinical concern persists despite a low estimated probability.
Wells Score in Clinical Practice
The Wells Score has been incorporated into numerous national and international guidelines for the investigation of suspected pulmonary embolism, including recommendations from organisations such as the National Institute for Health and Care Excellence (NICE), the European Society of Cardiology (ESC), and the American College of Chest Physicians (CHEST). Its widespread use reflects strong evidence supporting structured risk assessment and evidence-based diagnostic pathways.
Clinical Significance
The Wells Score for Pulmonary Embolism remains one of the most important clinical prediction tools for assessing suspected pulmonary embolism. By providing a structured estimate of pre-test probability, it supports appropriate use of D-dimer testing and diagnostic imaging, facilitates timely diagnosis, and contributes to evidence-based management of venous thromboembolism. When interpreted alongside comprehensive clinical assessment, laboratory investigations, imaging findings, and current clinical guidelines, the Wells Score plays a vital role in delivering safe and effective patient care.